Eidos Therapeutics, Inc. Debt to Equity Ratio 2018-2020 | EIDX
Current and historical debt to equity ratio values for Eidos Therapeutics, Inc. (EIDX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Eidos Therapeutics, Inc. debt/equity for the three months ending September 30, 2020 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2020-09-30 | $0.04B | $0.12B | 0.31 |
| 2020-06-30 | $0.04B | $0.15B | 0.25 |
| 2020-03-31 | $0.03B | $0.18B | 0.19 |
| 2019-12-31 | $0.03B | $0.17B | 0.19 |
| 2019-09-30 | $0.02B | $0.16B | 0.09 |
| 2019-06-30 | $0.01B | $0.13B | 0.06 |
| 2019-03-31 | $0.01B | $0.14B | 0.06 |
| 2018-12-31 | $0.01B | $0.16B | 0.03 |
| 2018-09-30 | $0.01B | $0.16B | 0.04 |
| 2018-06-30 | $0.01B | $0.17B | 0.03 |
| 2018-03-31 | $0.01B | $0.02B | 0.39 |
| 2017-12-31 | $0.00B | $0.00B | 0.66 |
| 2017-09-30 | $0.00B | 0.00 | |
| 2017-06-30 | $0.00B | 0.00 | |
| 2017-03-31 | $0.00B | 0.00 | |
